Manufactured for and Distributed by:
Aspire Air, Inc.
Minneapolis, MN 55442
612-518-7064
Aspire Air, Inc.
The Airborne Isolation Hood
Instructions for Health Care Workers
Product Name: The Airborne Isolation Hood
The U.S. Food and Drug Administration has issued an Emergency Use Authorization (EUA) for Airborne
Isolation Hood, for use by healthcare provider (HCP) as an additional layer of barrier protection in addition to
personal protective equipment (PPE) to prevent HCP exposure to pathogenic biological airborne particulates by
providing temporary isolation of hospitalized patients with suspected or confirmed diagnosis of COVID-19, at the
time of definitive airway management, when performing airway-related medical procedures, or during certain
transport of such patients during the COVID-19 pandemic.
Authorized non-transport use of Airborne Isolation Hood is only for definitive airway management (e.g., intubation,
extubating and suctioning airways), or when performing any airway-related medical procedures (e.g., high flow
nasal cannula oxygen treatments, nebulizer treatments, manipulation of oxygen mask or continuous positive
airway pressure/bi-level positive airway pressure [CPAP/BiPAP] mask use, airway suctioning, percussion and
postural drainage). Authorized use of Airborne Isolation Hood during patient transport is only within a hospital
setting for temporary transfer with direct admission within the hospital in the presence of a registered nurse or
physician. Maintenance of negative pressure with adequate air flow must be ensured. The patient should have
constant monitoring of vital signs, electrocardiogram (EKG), SpO2%, and EtCO2, if available, throughout
transport. If end-tidal CO2 monitoring is not available, then the use of the Airborne Isolation Hood Device must be
limited to no longer than 30 minutes with inline blower fan on and under direct observation. For all authorized
uses, the patient should always have supplemental oxygen during use of the Airborne Isolation Hood Device.
The Airborne Isolation Hood Device is for use in addition to PPE for HCP during the COVID-19 pandemic and
does not replace the need for PPE.
Airborne Isolation Hood has not been FDA-approved or cleared for this use; Airborne Isolation Hood has
been authorized for emergency use by FDA under an EUA. Airborne Isolation Hood has been authorized
only for the duration of the COVID-19 public health emergency declaration that circumstances exist justifying
the authorization of the emergency use of medical devices under section 564(b)(1) of the Federal Food, Drug
and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.
HCP should follow these instructions, as well as procedures at their healthcare facility to use the Airborne
Isolation Hood.
The instructions below are to assist in using Airborne Isolation Hood. Airborne Isolation
Hood
is an adjunctive protective barrier designed to mitigate risk to HCP. Airborne
Isolation Hood
is not meant to be a stand- alone unit of PPE. Airborne Isolation Hood
should always be used with appropriate PPE and pursuant to the guidance of your
institution.
All connections should be tightly secured and checked frequently. Any time anyone is within Airborne
Isolation Hood
, direct observation is required. Inspect Airborne Isolation Hood prior to use. Any
wear/tear of the chamber or other signs of degradation on
Airborne Isolation Hood must promptly be
reported to
Airborne Isolation Hood Medical Solutions Inc. The healthcare facility must not use on